The total return over the past 12 months is -79.77% vs. +16.94% for the S&P 500. So far it's up -75.38% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (79.77%) | (40.01%) | (46.02%) | N/A | N/A | N/A |
| Total Return CAGR | (79.77%) | (40.01%) | (46.02%) | N/A | N/A | N/A |
| Revenue CAGR | +50.82% | +98.41% | +37.21% | +173.28% | +67.00% | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | (151.81%) | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
NeuroOne Medical Technologies Corporation (NMTC)
| Year | Start price | End price | NMTC Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $4.55 | $1.12 | (75.38%) | +14.51% | (89.89%) |
| 2025 | $4.96 | $4.55 | (8.27%) | +17.72% | (25.99%) |
| 2024 | $9.48 | $4.96 | (47.68%) | +24.89% | (72.57%) |
| 2023 | $7.20 | $9.48 | +31.67% | +26.19% | +5.48% |
| 2022 | $11.64 | $7.20 | (38.14%) | (18.17%) | (19.97%) |
| 2021 | $28.26 | $11.64 | (58.81%) | +28.74% | (87.55%) |
| 2020 | $42.84 | $28.26 | (34.03%) | +18.37% | (52.40%) |
| 2019 | $100.08 | $42.84 | (57.19%) | +31.22% | (88.41%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
